Sipuleucel-T With Immediate vs. Delayed Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA-4) Blockade for Prostate Cancer
Clinical trial NCT01804465 · COMPLETED
Trial details
- NCT number
- NCT01804465
- Sponsor
- University of California, San Francisco
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-22
- Primary completion
- 2020-02-27
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.